Vitamin D3 Supplementation Enhances Symptom Relief and Modulates Microbiome and Immune Responses in Pediatric Post-Acute Sequelae of COVID-19: A Randomized Controlled Trial

Pei-Chi Chen; Tsunglin Liu; Yu-Ching Chuang; Yu-Lung Hsu; Yen-Hsi Chen; Chih-Yu Lin; Miao-Hsi Hsieh; Yu-Shan Ho; Xiao-Ling Liu; Wen-Shuo Kuo; Hui-Fang Kao; Shulhn-Der Wang; Hui-Ju Tsai; Lawrence Shih-Hsin Wu; Jiu-Yao Wang

Pei-Chi Chen, Tsunglin Liu, Yu-Ching Chuang, Yu-Lung Hsu, Yen-Hsi Chen, Chih-Yu Lin, Miao-Hsi Hsieh, Yu-Shan Ho, Xiao-Ling Liu, Wen-Shuo Kuo, Hui-Fang Kao, Shulhn-Der Wang, Hui-Ju Tsai, Lawrence Shih-Hsin Wu, Jiu-Yao Wang

doi:10.20944/preprints202602.0361.v1

Background: Post-acute sequelae ofCOVID-19 (PASC) in children present persistent symptoms that impair quality of life. Vitamin D's immunomodulatory and microbiome-modulating properties suggest its potential to alleviate PASC symptoms. This study evaluated the efficacy of Vitamin D3 supplementation in alleviating symptom severity and to explore associated immunological and microbiome alterations in children with PASC. Methods: In a double-blind randomized controlled clinical trial, 33 children with PASC were assigned to receive 2,000 IU/day of oral vitamin D (Group A, n=21) or placebo (Group B, n=12) for 6 months. Serum 25-hydroxyvitamin D [25(OH)D] levels, symptom severity (Children's Somatic Symptom Inventory-24, CSSI-24), immune cytokines, and checkpoint proteins were assessed at baseline (M0) and 6 months (M6). Nasal and rectal microbiota were analyzed using 16S rRNA sequencing to evaluate composition and predict functional pathways. Results: Serum 25(OH)D increased significantly in Group A compared with Group B (p < 0.01). Group A demonstrated significant reductions in CSSI-24 scores (p < 0.05), with improvements in neuropsychiatric, respiratory and cardiovascular symptoms. Pro-inflammatory cytokines including IFN-γ (FDR = 0.01) and MIP-1α (FDR = 0.0004) decreased, while checkpoint proteins TIM-3 and HVEM increased (both FDR < 0.05). Nasal microbiota in Group A at M6 showed increased richness and enrichment of Sphingomonas, Paenibacillus, Ralstonia, and Sphingobium, with functional pathways related to xenobiotic metabolism altered after supplementation. Coprobacillus abundance in rectal samples positively correlated with 25(OH)D levels and negatively with IFN-γ (p = 0.02). Pooling participants from both time points across group A indicated that higher 25(OH)D levels were associated with lower symptom scores. Conclusions: Vitamin D3 supplementation improved

Authors' contributions: PCC, YLH, LSHW, and JYW designed the study. YLH, MHH, and YSH performed clinical data collections. PCC and YLH coordinated and supervised data collection. TL and YCC analyzed the microbiome data. PCC, YHC, CYL, XLL, HJT, and LSHW analyzed the clinical data. PCC wrote the initial draft of the manuscript. TL, LSHW, and JYW reviewed and revised the manuscript. WSK, HFK, and SDW provided critical assessments during the revision process leading to the final submitted manuscript. All authors have reviewed and approved the final version of this manuscript.

References

Akimbekov, Digel, Sherelkhan, Lutfor, Razzaque, Vitamin D and the Host-Gut Microbiome: A Brief Overview, Acta Histochem Cytochem

Baktash, Hosack, Patel, Shah, Kandiah et al., Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J

Bellerba, Muzio, Gnagnarella, Facciotti, Chiocca et al., The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies, Nutrients

Cantorna, Mcdaniel, Bora, Chen, James, Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease, Exp Biol Med

Castillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol

Cătălina, Gheorman, Gheorman, Forțofoiu, The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases, Healthcare

Davis, Assaf, Mccorkell, Wei, Low et al., Characterizing long COVID in an international cohort: 7 months of symptoms and their impact, EClinicalMedicine

Durack, Lynch, Nariya, Bhakta, Beigelman et al., Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment, J Allergy Clin Immunol

Giannos, Prokopidis, Gut dysbiosis and long COVID-19: Feeling gutted, J Med Virol

Guo, Yi, Wu, Lu, The microbiome in post-acute infection syndrome (PAIS), Comput Struct Biotechnol J

Holick, Vitamin D deficiency, N Engl J Med

Hsu, Chen, Tsai, Wei, Wu et al., Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan, Vaccines

Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One

Kenny, Townsend, Savinelli, Mallon, Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets, Front Mol Biosci

Liu, Mak, Su, Yeoh, Lui et al., Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome, Gut

Louis, Flint, Formation of propionate and butyrate by the human colonic microbiota, Environ Microbiol

Martens, Gysemans, Verstuyf, Mathieu, Vitamin D's Effect on Immune Function, Nutrients

Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, Bmj

Meo, Alhusseini, Ibrahim, Meo, Ahsan et al., Clinical manifestations of Long-COVID: an observational perspective, Front Med

Mercola, Grant, Wagner, Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity, Nutrients

Nalbandian, Sehgal, Gupta, Madhavan, Mcgroder et al., Post-acute COVID-19 syndrome, Nat Med

Ooi, Chen, Cantorna, Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?, Mol Aspects Med

Phetsouphanh, Darley, Wilson, Howe, Munier et al., Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, Nat Immunol

Pichler, Coskun, Ortega-Arbulú, Conci, Wörheide et al., A 16S rRNA gene sequencing and analysis protocol for the Illumina MiniSeq platform, Microbiologyopen

Quesada-Gomez, Entrenas-Castillo, Bouillon, Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166, J Steroid Biochem Mol Biol

Raj, Bruce, Anbalagan, Srinivasan, Chinnappan et al., COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens, Front Cell Infect Microbiol

Rao, Gross, Mohandas, Stein, Case et al., Postacute Sequelae of SARS-CoV-2 in Children, Pediatrics

Singh, Rawat, Alwakeel, Sharif, Khodor, The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals, Sci Rep

Stephenson, Shafran, Ladhani, Long COVID in children and adolescents, Curr Opin Infect Dis

Torres-Sánchez, Ruiz-Rodríguez, Ortiz, Moreno, Ampatzoglou et al., Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach, Int J Mol Sci

Ullah, Gut-vitamin D interplay: key to mitigating immunosenescence and promoting healthy ageing, Immun Ageing

Walker, Beck, Garber, Children's Somatization Inventory: psychometric properties of the revised form (CSI-24), J Pediatr Psychol

Wykes, Lewin, Immune checkpoint blockade in infectious diseases, Nat Rev Immunol

Yong, Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments, Infect Dis (Lond)

Álvarez-Santacruz, Tyrkalska, Candel, The Microbiota in Long COVID, Int J Mol Sci

DOI record: { "DOI": "10.20944/preprints202602.0361.v1", "URL": "http://dx.doi.org/10.20944/preprints202602.0361.v1", "abstract": "Background :Post-acute sequelae of COVID-19 (PASC) in children present persistent symptoms that impair quality of life. Vitamin D’s immunomodulatory and microbiome-modulating properties suggest its potential to alleviate PASC symptoms. This study evaluated the efficacy of Vitamin D3 supplementation in alleviating symptom severity and to explore associated immunological and microbiome alterations in children with PASC. Methods: In a double-blind randomized controlled clinical trial, 33 children with PASC were assigned to receive 2,000 IU/day of oral vitamin D (Group A, n=21) or placebo (Group B, n=12) for 6 months. Serum 25-hydroxyvitamin D [25(OH)D] levels, symptom severity (Children’s Somatic Symptom Inventory-24, CSSI-24), immune cytokines, and checkpoint proteins were assessed at baseline (M0) and 6 months (M6). Nasal and rectal microbiota were analyzed using 16S rRNA sequencing to evaluate composition and predict functional pathways. Results: Serum 25(OH)D increased significantly in Group A compared with Group B (p &lt; 0.01). Group A demonstrated significant reductions in CSSI-24 scores (p &lt; 0.05), with improvements in neuropsychiatric, respiratory and cardiovascular symptoms. Pro-inflammatory cytokines including IFN-γ (FDR = 0.01) and MIP-1α (FDR = 0.0004) decreased, while checkpoint proteins TIM-3 and HVEM increased (both FDR &lt; 0.05). Nasal microbiota in Group A at M6 showed increased richness and enrichment of Sphingomonas, Paenibacillus, Ralstonia, and Sphingobium, with functional pathways related to xenobiotic metabolism altered after supplementation. Coprobacillus abundance in rectal samples positively correlated with 25(OH)D levels and negatively with IFN-γ (p = 0.02). Pooling participants from both time points across group A indicated that higher 25(OH)D levels were associated with lower symptom scores. Conclusions: Vitamin D3 supplementation improved symptom severity, modulated immune responses, and altered microbiota profiles in children with PASC. These findings support Vitamin D3 as a potential adjunctive therapy for pediatric PASC and highlight host–microbe–immune interactions as therapeutic targets.", "accepted": { "date-parts": [ [ 2026, 2, 4 ] ] }, "author": [ { "affiliation": [], "family": "Chen", "given": "Pei-Chi", "sequence": "first" }, { "affiliation": [], "family": "Liu", "given": "Tsunglin", "sequence": "additional" }, { "affiliation": [], "family": "Chuang", "given": "Yu-Ching", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-3010-2767", "affiliation": [], "authenticated-orcid": false, "family": "Hsu", "given": "Yu-Lung", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Yen-Hsi", "sequence": "additional" }, { "affiliation": [], "family": "Lin", "given": "Chih-Yu", "sequence": "additional" }, { "affiliation": [], "family": "Hsieh", "given": "Miao-Hsi", "sequence": "additional" }, { "affiliation": [], "family": "Ho", "given": "Yu-Shan", "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0000-3860-975X", "affiliation": [], "authenticated-orcid": false, "family": "Liu", "given": "Xiao-Ling", "sequence": "additional" }, { "affiliation": [], "family": "Kuo", "given": "Wen-Shuo", "sequence": "additional" }, { "affiliation": [], "family": "Kao", "given": "Hui-Fang", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Shulhn-Der", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-5338-6117", "affiliation": [], "authenticated-orcid": false, "family": "Tsai", "given": "Hui-Ju", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-6275-8368", "affiliation": [], "authenticated-orcid": false, "family": "Wu", "given": "Lawrence Shih-Hsin", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Jiu-Yao", "sequence": "additional" } ], "container-title": [], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2026, 2, 9 ] ], "date-time": "2026-02-09T00:12:46Z", "timestamp": 1770595966000 }, "deposited": { "date-parts": [ [ 2026, 2, 9 ] ], "date-time": "2026-02-09T00:13:02Z", "timestamp": 1770595982000 }, "group-title": "Medicine and Pharmacology", "indexed": { "date-parts": [ [ 2026, 2, 9 ] ], "date-time": "2026-02-09T17:05:14Z", "timestamp": 1770656714425, "version": "3.49.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2026, 2, 5 ] ] }, "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 2, 5 ] ], "date-time": "2026-02-05T00:00:00Z", "timestamp": 1770249600000 } } ], "member": "1968", "original-title": [], "posted": { "date-parts": [ [ 2026, 2, 5 ] ] }, "prefix": "10.20944", "published": { "date-parts": [ [ 2026, 2, 5 ] ] }, "publisher": "MDPI AG", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://www.preprints.org/manuscript/202602.0361/v1" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "subtype": "preprint", "title": "Vitamin D3 Supplementation Enhances Symptom Relief and Modulates Microbiome and Immune Responses in Pediatric Post-Acute Sequelae of COVID-19: A Randomized Controlled Trial", "type": "posted-content" }